☆ 4.4 Letter

Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial and Re: CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE NATIONAL CANCER INSTITUTE
Volume 104, Issue 16, Pages 1263-1264

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/jnci/djs312

Keywords

-

Categories

Oncology

Funding

  1. National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.